» Articles » PMID: 23224084

Efficient Depletion of Host DNA Contamination in Malaria Clinical Sequencing

Overview
Specialty Microbiology
Date 2012 Dec 11
PMID 23224084
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

The cost of whole-genome sequencing (WGS) is decreasing rapidly as next-generation sequencing technology continues to advance, and the prospect of making WGS available for public health applications is becoming a reality. So far, a number of studies have demonstrated the use of WGS as an epidemiological tool for typing and controlling outbreaks of microbial pathogens. Success of these applications is hugely dependent on efficient generation of clean genetic material that is free from host DNA contamination for rapid preparation of sequencing libraries. The presence of large amounts of host DNA severely affects the efficiency of characterizing pathogens using WGS and is therefore a serious impediment to clinical and epidemiological sequencing for health care and public health applications. We have developed a simple enzymatic treatment method that takes advantage of the methylation of human DNA to selectively deplete host contamination from clinical samples prior to sequencing. Using malaria clinical samples with over 80% human host DNA contamination, we show that the enzymatic treatment enriches Plasmodium falciparum DNA up to ∼9-fold and generates high-quality, nonbiased sequence reads covering >98% of 86,158 catalogued typeable single-nucleotide polymorphism loci.

Citing Articles

Turning the needle into the haystack: Culture-independent amplification of complex microbial genomes directly from their native environment.

Pilling O, Sundararaman S, Brisson D, Beiting D PLoS Pathog. 2024; 20(9):e1012418.

PMID: 39264872 PMC: 11392400. DOI: 10.1371/journal.ppat.1012418.


Trends and Developments in the Detection of Pathogens in Central Nervous System Infections: A Bibliometric Study.

Guo Y, Yang Y, Xu M, Shi G, Zhou J, Zhang J Front Cell Infect Microbiol. 2022; 12:856845.

PMID: 35573778 PMC: 9100591. DOI: 10.3389/fcimb.2022.856845.


Metagenomic Sequencing for Microbial DNA in Human Samples: Emerging Technological Advances.

Shi Y, Wang G, Lau H, Yu J Int J Mol Sci. 2022; 23(4).

PMID: 35216302 PMC: 8877284. DOI: 10.3390/ijms23042181.


Development and evaluation of a ligation-free sequence-independent, single-primer amplification (LF-SISPA) assay for whole genome characterization of viruses.

Jothikumar N, Cromeans T, Shivajothi J, Vinje J, Murphy J J Virol Methods. 2021; 299:114346.

PMID: 34740706 PMC: 11075090. DOI: 10.1016/j.jviromet.2021.114346.


Single-cell sequencing of the small and AT-skewed genome of malaria parasites.

Liu S, Huckaby A, Brown A, Moore C, Burbulis I, McConnell M Genome Med. 2021; 13(1):75.

PMID: 33947449 PMC: 8094492. DOI: 10.1186/s13073-021-00889-9.


References
1.
MacDermed D, Uribe-Bruce L . Diverse perspectives on the current state of genomic medicine: has the revolution begun?. Genome Med. 2011; 3(5):27. PMC: 3219068. DOI: 10.1186/gm241. View

2.
Oyola S, Otto T, Gu Y, Maslen G, Manske M, Campino S . Optimizing Illumina next-generation sequencing library preparation for extremely AT-biased genomes. BMC Genomics. 2012; 13:1. PMC: 3312816. DOI: 10.1186/1471-2164-13-1. View

3.
Cohen-Karni D, Xu D, Apone L, Fomenkov A, Sun Z, Davis P . The MspJI family of modification-dependent restriction endonucleases for epigenetic studies. Proc Natl Acad Sci U S A. 2011; 108(27):11040-5. PMC: 3131316. DOI: 10.1073/pnas.1018448108. View

4.
Melnikov A, Galinsky K, Rogov P, Fennell T, Van Tyne D, Russ C . Hybrid selection for sequencing pathogen genomes from clinical samples. Genome Biol. 2011; 12(8):R73. PMC: 3245613. DOI: 10.1186/gb-2011-12-8-r73. View

5.
Pallen M, Loman N . Are diagnostic and public health bacteriology ready to become branches of genomic medicine?. Genome Med. 2011; 3(8):53. PMC: 3238179. DOI: 10.1186/gm269. View